Autism is a common neuropsychiatric disorder affecting 1 in 68 children. Copy number variations (CNVs) are known to be major contributors of autism spectrum disorder (ASD). There are different whole genome or targeted techniques to identify CNVs in the patients including karyotyping, multiplex ligation-dependent probe amplification (MLPA) and array CGH. In this study, we used karyotyping and MLPA to detect CNVs in 50
novo and three others were paternally inherited. Two of CNVs detected by karyotyping and MLPA tests were 16p13.1q13.3 and 10q26.3 duplications, respectively. For these two CNVs genotype and phenotype of the patients were compared with other studies. Although the pathogenicity of cytogenetic results was certain, most of MLPA results needed to be better refined using other more accurate techniques such as array CGH. Our findings suggest that it might be possible to obtain some useful information using MLPA technique but it cannot be used as a single diagnostic tool for the autism. ASD is the most heritable of all neuropsychiatric disorders (4) and genetic factors play an important role in the etiology of autism.
Copy number variants are known to be major contributors with the overall rate of 10-15% in children with autism from which 3-7% are cytogenetically detectable chromosome abnormalities (5) (6) (7) (8) and the remaining could be identified using molecular cytogenetic techniques (9, 10) .
This rate increases when autism co-occurs with other clinical features, suggesting a syndromic forms of autism (11) (12) (13) (14) (15) . Furthermore, de novo CNVs appear to be a more common risk factor in sporadic cases of ASD (12, 16) .
Almost every chromosome has been demonstrated to be involved in imbalances contributing to autism (8, 17 and also in the SHANK2, an autism candidate gene.
Materials and methods

Subjects
Clinical evaluation was carried out for the patients with ASD diagnosis. Fifty patients who met the DSM5 criteria diagnosed by pediatric neurologists specializing in autism were selected.
All patients were sporadic with no family history of ASD. The selected patients had ID with one or more additional clinical features.
GTG banding
High resolution GTG banding technique was carried out using standard protocols.
MLPA
The following 4 kits were used: SALSA P070-B2 and P036-E2 human subtelomere kits 
Results
Two out of 50 patients demonstrated chromosome abnormalities (4%) including one duplication on chromosome 16p and one deletion on chromosome 15q. Furthermore, all patients were investigated using 4 MLPA kits (Table 1 ). In one patient, different results were obtained using the subtelomeric kits (P036 and P070) that was a consequence of different genomic location of probes in two probemixes. As a result, copy number changes were demonstrated in 4 (8%) and 3(6%) patients using P036 and P070 kits, respectively. Utilizing the P343 kit, two (4%) CNVs were observed in the patients. However, none of the patients showed SHANK2 deletions with the P396 kit. Since some of the results were overlapping (Table 2) , the total detection rate utilizing cytogenetic and MLPA analysis was 12% and MLPA showed a detection rate of 10%. Out of 6 abnormalities observed in the patients, 3 were de novo and 3 were paternally inherited. Additional clinical features presented in autism patients with copy number changes are shown in Table 3 . 
Xp22.33 duplication
Different studies have shown that many genomic rearrangements occur in the subtelomeric region of Xp which can cause various disorders including autism (15, 42, 43) . In spite of that, the copy number gain in our patient (p32) has been inherited from his normal father and it seems to be a benign CNV. Thus the autism and other clinical features in patient p32 are probably caused by the other copy number or single nucleotide variation(s) which need more accurate and whole genome techniques to be identified. 
